• Article metrics
  • Last updated: Thu, 9 Oct 2025 22:02:09 Z

Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial

Access & Citations

  • 8736
    Article Accesses
  • 68
    Citations

Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.

Online attention

Altmetric score 1
  • 1 tweeters
  • 26 Mendeley

This article is in the 13th percentile (ranked 328,166th) of the 437,534 tracked articles of a similar age in all journals and the 6th percentile (ranked 99th) of the 115 tracked articles of a similar age in Signal Transduction and Targeted Therapy

View more on Altmetric

Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.